Pharmaceutical Executive Europe - October 2008 - (Page 12)

Small Company, Big Career The days of a job for life at a Big Pharma company seem to be well behind us, but that doesn’t mean we should view the employment landscape with trepidation. In fact, it’s quite the opposite, according to a number of executives who have made successful moves from Big Pharma to small pharmaceutical companies and the agencies that helped them do it. Julian Upton reports. A 15 Executive Recruitment The value of recruiting experts on an as needed basis 19 Meet unmet needs Natalie Douglas on named patient programmes 22 Pharma in Turkey Interviews with the country’s leading executives 37 Last words Who said what in pharma’s last four weeks Dimitri Vervitsiotis/Getty Images s the industry landscape evolves, more and more pharma professionals are moving away from old-style ‘jobs for life’ and into less secure, but more challenging and, in many ways, more exciting work environments. This is particularly the case for senior-level personnel and executives, who often regard the challenge of helping to build up a small, start-up company more highly than they do a high salary or a spacious, oak-finished office. Similarly, there is growing acceptance that a bit of variety on one’s CV — indicating adaptability, flexibility and a willingness to take professional risks — is more attractive to a potential employer than a lengthy time-served apprenticeship at a behemoth-s pharma company. It’s no secret that big, multinational companies are not as safe as they once were. With recent redundancy announcements, the market place is becoming more crowded with ex-Big Pharma employees who may very much need, as well as want, to ‘downshift.’ The good news is that the small-to-medium-sized company landscape is an attractive and fairly buoyant option for those looking to ‘make their mark.’ “In a small company, you can become a star; you can shine more,” says Ugo Bettini, vice president of Human Resources at Chiesi (Italy). “We may offer less money than some other companies, but we give employees a visibility within the company that they wouldn’t necessarily get in Big Pharma. Salary won’t be the motivating factor for someone coming here — it is a different experience.” Indeed, an experience that would involve relocating to the beautiful city of Parma.

Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - October 2008

Pharmaceutical Executive Europe - October 2008 Contents News and Analysis Calendar BioFutures Strategy Fundamentals Executive Recruitment: Small Company, Big Career Executive Recruitment: Instant Pharma Named Patient Programmes Executive Review: Turkey

Pharmaceutical Executive Europe - October 2008

Pharmaceutical Executive Europe - October 2008 - Pharmaceutical Executive Europe - October 2008 (Page 1) Pharmaceutical Executive Europe - October 2008 - Contents (Page 2) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 3) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 4) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 5) Pharmaceutical Executive Europe - October 2008 - Calendar (Page 6) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 7) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 8) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 9) Pharmaceutical Executive Europe - October 2008 - Strategy Fundamentals (Page 10) Pharmaceutical Executive Europe - October 2008 - Strategy Fundamentals (Page 11) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 12) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 13) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 14) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 15) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 16) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 17) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 18) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 19) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 20) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 21) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 22) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 23) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 24) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 25) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 26) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 27) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 28) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 29) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 30) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 31) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 32) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 33) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 34) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 35) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 36) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 37) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC1) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC2) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC3) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC4) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC5) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC6) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC7) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC8) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC9) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC10) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC11) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC12) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC13) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC14) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC15) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC16) http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090812http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090805http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090729http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafricahttp://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.